Chemists at Indiana University Bloomington have produced detailed
descriptions of the structure and molecular properties of human folate
receptor proteins, a key development for designing new drugs that can
target cancer and inflammatory diseases without serious side effects.
Credit: http://newsinfo.iu.edu